Men's reactions to disclosed and undisclosed opportunistic PSA screening for prostate cancer

Medical Journal of Australia

Volumn 182, Issue 8, 2005, Pages 386-389

  Gattellari, Melina ^a   Ward, Jeanette E ^b  

^a UNIVERSITY OF NEW SOUTH WALES   (Australia)

^b SYDNEY SOUTH WEST AREA HEALTH SERVICE   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

PROSTATE SPECIFIC ANTIGEN;

ADULT; AGED; ANTIGEN DETECTION; ARTICLE; AUSTRALIA; CANCER SCREENING; CONTROLLED STUDY; DEMOGRAPHY; EXPECTATION; GENERAL PRACTITIONER; HEALTH CARE QUALITY; HEALTH STATUS; HISTOPATHOLOGY; HUMAN; HYPOTHESIS; INFORMED CONSENT; INTERPERSONAL COMMUNICATION; MAJOR CLINICAL STUDY; MALE; MEDICAL ASSESSMENT; PATIENT ATTITUDE; PATIENT EDUCATION; PATIENT SELECTION; PROSTATE CANCER; QUESTIONNAIRE; TELEPHONE;

EID: 17644421460     PISSN: 0025729X     EISSN: None     Source Type: Journal    
DOI: 10.5694/j.1326-5377.2005.tb06756.x     Document Type: Article

References (27)

1. Catalona WJ. Informed consent for prostate-specific antigen screening. Urology 2003; 61: 17-19.
2. Stricker PD, Eisenger DR. Patient preference and prostate cancer screening. Med J Aust 1997; 167: 240-241.
3. Talcott JA. What patients should be told before agreeing to a blood test that could change their lives. Urology 2000; 61: 7-9.
4. Woolf SH, Rothemich SF. Screening for prostate cancer: the roles of science, policy, and opinion in determining what is best for patients. Annu Rev Med 1999; 50: 207-221.
5. Harris R, Lohr KN. Screening for prostate cancer: an update of the evidence for the US Preventive Services Task Force. Ann Intern Med 2002; 137: 917-929.
6. National Cancer Institute, US National Institutes of Health. Prostate cancer: screening and testing. Available at: http://www.nci.nih.gov/cancer_information/testing (accessed Feb 2005).
7. Feightner JW. Screening for prostate cancer. In: The Canadian guide to clinical preventive health care. Canadian Task Force on Preventive Health Care. Available at: http://www.ctf-phc.org/Sections/section10chO67.htm (accessed Feb 2005).
8. Canadian Cancer Society. Prostate specific antigen (PSA) test for prostate cancer. 2005. Available at: http://www.ontario.cancer.ca/ccs/internet/standard/ 0,3182,3543_10175_275266_langld-en,00.html(accessed March 2005).
9. UK National Health Service. Prostate cancer risk management. Available at: http://www.cancer-screening.nhs.uk/prostate/index.html (accessed Feb 2005).
10. Diefenbach PN, Ganz PA, Pawlow AJ, Guthrie D. Screening by the prostate-specific antigen test: what do the patients know? J Cancer Educ 1996; 11: 39-44.
11. Federman DG, Goyal S, Kamina A, et al. Informed consent for PSA screening: does it happen? Effect Clin Pract 1999; 2: 152-157.
12. Slevin TJ, Donnelly N, Clarkson JP, et al. Prostate cancer testing: behaviour, motivation and attitudes among Western Australian men. Med J Aust 1999; 171: 185-188.
13. Gattellari M, Young JM, Ward J. GP and patient predictors of PSA screening in Australian general practice. Fam Pract 2003; 10: 27-39.
14. Gattellari M, Ward JE. A community-based randomised controlled trial of three different educational resources for men about prostate cancer screening. Patient Educ Counsel 2005. In press.
15. Gattellari M, Ward JE. A community study using specified and unspecified scenarios to investigate men's views about PSA screening. Health Expectations 2004; 7: 274-289. Available at: http://www.blackwell-synergy.com/links/doi/10.1111/ j.1369-7625.2004.00285.x/enhancedabs (accessed Mar 2005).
16. Lau RR. Origins of health locus of control beliefs. J Pers Soc Psychol 1982; 42: 322-334.
17. Hosmer DW, Lemeshow S. Applied logistic regression. Brisbane: John Wiley and Sons, 2001.
18. SPSS for Windows. Release 12.0. User's guide. Chicago, III: SPSS Inc, 2003.
19. Ward JE, Hughes AM, Hirst GHL, Winchester L. Men's estimates of prostate cancer risk and self-reported rates of screening. Med J Aust 1997; 167: 250-253.
20. Ware J. SF36 health survey: manual and interpretation guide. Boston: The Health Institute, 1993.
21. Marshall GN, Collins BE, Crooks VC. A comparison of two multidimensional health locus of control instruments. J Pers Assess 1990; 54: 181-190.
22. Degner LF, Sloan JA, Venkatesh P. The control preferences scale. Can J Nurs Res 1997; 29: 21-43.
23. Ransohoff DF, McNaughton Collins M, Fowler FJ. Why is prostate cancer screening so common when the evidence is so uncertain? A system without negative feedback. Am J Med 2002; 113: 663-667.
24. Guaganoli E, Ward P. Patient participation in decision-making. Soc Sci Med 1998; 3: 329-339.
25. Benbassat J, Pilpel D, Tidhar M. Patients' preferences for participation in clinical decision making: a review of published surveys. Behav Med 1998; 24: 81-88.
26. Davison BJ, Kirk P, Degner LF, Hassard TH. Information and patient participation in screening for prostate cancer. Patient Educ Counsel 1999; 37: 255-263.
27. Pauker SG, Kassierer JP. Contentious screening decisions: does choice matter? N Engl J Med 1997; 336: 1243-1244.